Value Proposition:
· Quantification and PET imaging of microglial cells in the brain
· Diagnostic for neuroinflammatory disorders – Alzheimer’s and MS
· Favorable compound half-life enables shipping
· Potential for non-CNS applications
Technology Description
Researchers at Johns Hopkins have developed a series of Positron Emission Tomography (PET) radiotracers for imaging activated microglia in neuroinflammatory disorders. The group synthesized multiple 18F-modified radiotracers targeting the microglia marker CSF1R. These compounds are compatible for in vivo, ex vivo, and in vitro PET imaging of brain tissue, with potential for non-CNS applications. Additionally, the nature of the 18F isotope allows for easy handling and shipping due to their longer half-life.
Stage of Development
Studies completed in murine models and non-human primates.
Data Availability
Data available upon request.
Publication
Horti et al. PNAS 116:1686-1691.